Related Experiment Video
Updated: Jul 17, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Causal Associations Between Gut Microbiota and Psoriasis: A Mendelian Randomization Study
Chenyang Zang1,2,3,4,5, Jie Liu5, Manyun Mao1,2,3,4
1The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.
Introduction:
Previous studies have proposed a possible gut-skin axis, and linked gut microbiota to psoriasis risks. However, there is heterogeneity in existing evidence. Observational research is prone to bias, and it is hard to determine causality. Therefore, this study aims to evaluate possible causal associations between gut microbiota (GM) and psoriasis.
Methods:
With published large-scale GWAS (genome-wide association study) summary datasets, two-sample Mendelian randomization (MR) was performed to sort out possible causal roles of GM in psoriasis and arthropathic psoriasis (PsA). The inverse variance weighted (IVW) method was taken as the primary evaluation of causal association. As complements to the IVW method, we also applied MR-Egger, weighted median. Sensitivity analyses were conducted using Cochrane's Q test, MR-Egger intercept test, MR-PRESSO (Mendelian Randomization Pleiotropy RESidual Sum and Outlier) global test, and leave-one-out analysis.
Results:
By primary IVW analysis, we identified nominal protective roles of Bacteroidetes (odds ratio, OR 0.81, P = 0.033) and Prevotella9 (OR 0.87, P = 0.045) in psoriasis risks. Bacteroidia (OR 0.65, P = 0.03), Bacteroidales (OR 0.65, P = 0.03), and Ruminococcaceae UCG002 (OR 0.81, P = 0.038) are nominally associated with lower risks for PsA. On the other hand, Pasteurellales (OR 1.22, P = 0.033), Pasteurellaceae (OR 1.22, P = 0.033), Blautia (OR 1.46, P = 0.014), Methanobrevibacter (OR 1.27, P = 0.026), and Eubacterium fissicatena group (OR 1.21, P = 0.028) are nominal risk factors for PsA. Additionally, E. fissicatena group is a possible risk factor for psoriasis (OR 1.22, P = 0.00018). After false discovery rate (FDR) correction, E. fissicatena group remains a risk factor for psoriasis (PFDR = 0.03798).
Conclusion:
We comprehensively evaluated possible causal associations of GM with psoriasis and arthropathic psoriasis, and identified several nominal associations. E. fissicatena group remains a risk factor for psoriasis after FDR correction. Our results offer promising therapeutic targets for psoriasis clinical management.
Insights
This study used Mendelian randomization to investigate the causal link between gut microbiota and psoriasis. The Eubacterium fissicatena group was identified as a risk factor for psoriasis, suggesting potential therapeutic targets.
Area of Science:
- Microbiome research
- Dermatology
- Genetics
Background:
- The gut-skin axis suggests a link between gut microbiota and psoriasis.
- Existing evidence is heterogeneous, and causality is difficult to establish through observational studies.
Purpose of the Study:
- To evaluate potential causal associations between gut microbiota (GM) and psoriasis.
- To investigate the role of GM in psoriatic arthritis (PsA).
Main Methods:
- Two-sample Mendelian randomization (MR) using large-scale GWAS summary datasets.
- Inverse variance weighted (IVW) method as the primary analysis.
- Sensitivity analyses including MR-Egger, weighted median, Cochrane's Q test, MR-Egger intercept test, MR-PRESSO, and leave-one-out analysis.
Main Results:
- Nominal protective roles were found for Bacteroidetes and Prevotella in psoriasis.
- Bacteroidia, Bacteroidales, and Ruminococcaceae UCG002 were nominally associated with lower PsA risk.
- Pasteurellales, Pasteurellaceae, Blautia, Methanobrevibacter, and Eubacterium fissicatena group were nominally associated with increased PsA risk.
- The E. fissicatena group was identified as a risk factor for psoriasis, even after FDR correction.
Conclusions:
- Several nominal causal associations between gut microbiota and psoriasis/PsA were identified.
- The E. fissicatena group is a confirmed risk factor for psoriasis.
- These findings may offer novel therapeutic targets for psoriasis management.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

